NurExone Demonstrates Scalable Exosome Production, Supporting Its Modular Manufacturing Strategy and Commercial Growth
Successful parallel production process maintains consistency while doubling exosome yield without increasing manufacturing time Successful parallel production process maintains consistency while doubling exosome yield without increasing manufacturing time
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.